-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOFRONTERA INC. ANNOUNCES HIGHLY SIGNIFICANT RESULTS IN PHASE 3 STUDY OF AMELUZ®-PHOTODYNAMIC THERAPY (PDT) REGARDING THE TREATMENT OF SUPERFICIAL BASAL CELL CARCINOMA (SBCC)

Reuters·10/31/2024 14:32:00

Please log in to view news